FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a therapy of a bronchoconstrictive condition and can be used for treating allergic rhinitis, asthma and chronic obstructive pulmonary disease (COPD). To this effect, a composition containing pentameric type A procyanidin in the concentration from approximately 55 wt/wt % to approximately 99 wt/wt %, trimeric procyanidin and tetrameric procyanidin, each in the concentration from approximately 0.5 wt/wt % to approximately 35 wt/wt % together with one or more pharmaceutical excipients in the concentration from approximately 0.5% to approximately 99.9% is administered into an individual in need thereof.
EFFECT: invention provides treating the bronchoconstrictive conditions without inducing side effects.
8 cl, 4 tbl, 6 ex
